<DOC>
	<DOCNO>NCT00611169</DOCNO>
	<brief_summary>The purpose study investigate whether administration high-dose tirofiban primary PCI could reduce myocardial infarct size , use analysis contrast-enhanced magnetic resonance imaging .</brief_summary>
	<brief_title>The Effects Facilitated Percutaeous Coronary Intervention Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<criteria>presence chest pain 30 minute less 12 hour symptom onset STsegment elevation 1 mm two contiguous lead presumably newonset leave bundle branch blockage hemodynamic instability history MI old age &gt; 80years Patients bleed diathesis ( coagulopathy , thrombocytopenia platelet dysfunction , Gastrointestinal genitourinary bleeding within prior 3 month )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Angioplasty , Transluminal , Percutaneous Coronary</keyword>
	<keyword>tirofiban</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Myocardial Infarction</keyword>
</DOC>